Metagenomi Therapeutics, Inc. (MGX) earnings
MGX earnings moved a median of -4.52% by the close. Quarterly and annual MGX reports and results, each read against the price at its own news timestamp. Back to the MGX overview →
19 measured MGX earnings events.
Where these MGX earnings landedvs 19 measured MGX earnings reactions
| Middle 50% of MGX earnings reactions | -7.00% to +1.04% |
|---|---|
| Median reaction (to close) | -4.52% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 MGX earnings events with a measured close landed between -7.00% and +1.04%; 32% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Metagenomi Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +2.63% | -0.49% | |
| Metagenomi Therapeutics Announces FDA Clearance of Investigational New Drug Application for MGX-001 and Reports Third Quarter 2026 Financial Results | Press release | +2.63% | -0.49% | |
| Form 10-Q Metagenomi Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.54% | +3.85% | |
| Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results | Press release | +1.54% | +3.85% | |
| Form 10-K Metagenomi Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.57% | -4.52% | |
| Form 10-Q Metagenomi, Inc. For: Sep 30 | SEC filing · Form 10-Q | -6.00% | -7.00% | |
| Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates | Press release | -6.00% | -7.00% | |
| Form 10-Q Metagenomi, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.08% | +1.04% | |
| Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results | Press release | -2.08% | +1.04% | |
| Form 10-Q Metagenomi, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.48% | -6.83% | |
| Metagenomi Reports Business Updates and First Quarter 2025 Financial Results | Press release | -2.48% | -6.83% | |
| Form 10-K Metagenomi, Inc. For: Dec 31 | SEC filing · Form 10-K | -4.87% | -6.49% | |
| Form 10-Q Metagenomi, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.09% | -18.26% | |
| Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results | Press release | -3.09% | -18.26% | |
| Form 10-Q Metagenomi, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.15% | -8.82% | |
| Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results | Press release | -0.15% | -8.82% | |
| Form 10-Q Metagenomi, Inc. For: Mar 31 | SEC filing · Form 10-Q | +4.05% | +4.62% | |
| Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results | Press release | +4.05% | +4.62% | |
| Form 10-K Metagenomi, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.36% | -0.89% |
Keep exploring
More MGX: analyst actions → · SEC filings → · MGX overview →